Cancer Calculus Latest breaking news, pictures, photos and Video News. Find Cancer Calculus news headlines, photos, videos, ...
Once a company product is delivered through the legitimate supply chain to a distributor, the company does not have ...
Merck Taiwan optoelectronics head Li Yung-li (李勇立) said the company supports industrial innovation. He added that ...
Merck presented integrated materials and inspection tools at Touch Taiwan 2026 as the panel industry pivots toward ...
Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: The Merck logo is seen at a gate to the Merck & Co campus in Rahway, New Jersey, U.S., July 12, 2018. REUTERS/Brendan ...
Rahway-based pharma giant Merck plans to spend $6.7 billion to purchase Terns Pharmaceuticals in an effort to boost its hematology pipeline. As part of the deal, Merck gains access to an experimental ...
Merck & Co. agreed to buy Terns Pharmaceuticals Inc. for $6.7 billion, giving the multinational company access to a promising new leukemia treatment as it faces the patent expiration of its ...
26d
Merck buying Terns in $6.7B deal to bolster its cancer portfolio before key Keytruda patent expires
Merck is buying oncology company Terns Pharmaceuticals in a deal valued at approximately $6.7 billion as the pharmaceutical giant works on beefing up its cancer portfolio before a key patent on ...
A Merck & Co. researcher at work. Merck has agreed to acquire Terns Pharmaceuticals for approximately $6.7 billion, in a deal designed to bolster the buyer’s cancer pipeline with that of Terns—led by ...
Facing vaccine pressures in multiple markets, Merck & Co. is pruning the ranks at one of its key U.S. production facilities. In a Worker Adjustment and Retraining Notification (WARN) Act alert filed ...
Atinvicitinib tablets (Numelvi) will control pruritus associated with allergic dermatitis in canines. Merck Animal Health announced today that the FDA has approved atinvicitinib tablets (Numelvi), ...
Merck & Co. is splitting its main pharmaceutical unit in two in an effort to better highlight the parts of the business that are growing, as it stares down a patent cliff for its best-selling cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results